Exhibiting at FOOD INGREDIENTS CHINA 2025

Healtang supports customized specifications, including mesh size, purity grades, and packaging formats for B2B buyers.

Specialisation and Core USP

The company’s specialization lies in:

• Advanced enzymatic hydrolysis and separation technologies
• Production of rare and value-added sugars from renewable plant biomass
• Proven scale-up capacity for both common and novel carbohydrate molecules
• Deep experience with food-grade, pharmaceutical-grade, and research-grade standards

Its USP is its capability to offer a full spectrum of pentose and hexose derivatives, including those with limited global supply.

Financials and Operational Scale

Operating as a subsidiary under Shandong Shengquan Group, Healtang benefits from significant industrial backing:

• Estimated annual revenue: USD 15–25 million
• Manufacturing facilities cover over 20,000 square meters
• Annual production capacities:
  • L-Arabinose: 2,000+ MT
  • Xylooligosaccharide: 3,000+ MT
  • Xylitol and derivatives: 5,000+ MT
• Exports to over 50 countries across Europe, Southeast Asia, North America, and the Middle East

Shipment and Export Data

According to industry platforms and trade databases:

• Over 120 recorded international shipments between 2020 and 2024
• Major export destinations: Germany, South Korea, India, USA, Indonesia
• Primary exports: L-Arabinose, XOS, and D-Xylose
• Shipment values per container: USD 12,000–50,000, depending on volume and purity

The company offers OEM labeling, bulk export packaging, and flexible MOQs for international clients.

Target Market

• Nutraceutical companies producing functional foods and supplements
• Pharmaceutical manufacturers requiring rare sugar intermediates
• Food and beverage producers formulating with low-GI or prebiotic ingredients
• Cosmetic and personal care brands seeking sugar-derived actives
• Biotech labs and research institutes

Healtang serves clients both directly and via global distribution partners.

Capabilities

• Fermentation and enzymatic bioconversion systems
• Industrial-scale chromatographic purification and crystallization
• R&D labs for structure-function analysis and application testing
• Full traceability and batch record management
• Support for custom development of new sugar molecules and derivatives

The company collaborates with universities and national research centers for innovation in carbohydrate biochemistry.

Certifications and Compliance

• ISO 9001:2015 Quality Management
• HACCP Certified
• Halal and Kosher Certification
• Products meet requirements of GB (China), EU Food Additive Regulation (EFSA), and US FDA GRAS
• Documentation includes COA, MSDS, TDS, and analytical method support

Regulatory support is available for global product registration and compliance dossiers.

Customer Testimonials

Feedback from international buyers consistently notes:

• High product purity and batch consistency
• Competitive pricing in the rare sugar category
• Responsive technical and logistics coordination
• Reliable lead times for bulk and contract orders

Customers in the EU dietary supplement sector report excellent gut health outcomes from XOS and consistent performance of L-Arabinose in blood sugar control formulas.

Major Achievements

• Recognized as a Key Export-Oriented Biotech Enterprise by the Jinan Municipal Government (2021)
• Awarded National High-Tech Enterprise Certification
• Developed proprietary production lines for L-Ribose and 2-Deoxy-L-Ribose
• Participated in China-EU Biotech Ingredient Collaboration Program
• Filed multiple patents on xylo-based oligosaccharide production processes

Healtang Biotech Co., Ltd. continues to lead in rare sugar innovation, providing scalable, sustainable, and science-backed ingredient solutions to the world’s food, health, and pharmaceutical industries.